What penicillin (antibiotic) is effective in treating a urinary tract infection (UTI) caused by Aerococcus, as indicated by a urine analysis (UA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Aerococcus Urinary Tract Infection

For Aerococcus UTI, use amoxicillin or penicillin as first-line therapy, with nitrofurantoin as an alternative for uncomplicated cystitis. 1, 2, 3

First-Line Penicillin Options

Amoxicillin or penicillin are the drugs of choice for Aerococcus urinae UTI based on excellent in vitro susceptibility and clinical experience. 2, 3, 4

  • Amoxicillin-clavulanate 20-40 mg/kg per day in 3 divided doses (or standard adult dosing of 500-875mg twice daily) is recommended for oral treatment 5
  • Penicillin demonstrates low MICs against Aerococcus urinae with minimal inter-isolate variability 2
  • Ampicillin is equally effective if susceptibility is confirmed 6, 4

Alternative Oral Options for Uncomplicated Cystitis

Nitrofurantoin 100mg four times daily achieves clinical and microbiological success in 71%/76% of A. urinae cystitis cases. 7

  • Fosfomycin 3g single dose is an alternative option for uncomplicated A. urinae cystitis 1
  • Pivmecillinam has demonstrated success in patients with A. urinae cystitis 7

Parenteral Options for Severe or Complicated Infections

For pyelonephritis or complicated UTI, use ceftriaxone 75 mg/kg every 24 hours or cefotaxime 150 mg/kg per day divided every 6-8 hours. 1

  • Ciprofloxacin achieved success in patients with pyelonephritis caused by A. urinae 7
  • For serious infections (bacteremia, endocarditis), penicillin or ampicillin combined with gentamicin provides rapid bactericidal activity 6, 2
  • Penicillin or vancomycin alone exhibit slow or no bactericidal activity; combination with gentamicin is essential for severe cases 2

Treatment Duration

Treat uncomplicated Aerococcus cystitis for 7 days. 1

  • For complicated UTI or pyelonephritis, use 7-14 days of therapy 5
  • Courses shorter than 7 days are inferior and should be avoided 5

Critical Clinical Considerations

Obtain urine culture with susceptibility testing before initiating treatment, as Aerococcus is frequently misidentified as streptococci or staphylococci on Gram stain. 1, 4

  • MALDI-TOF mass spectrometry provides rapid and accurate identification of Aerococcus species 4
  • Differentiate between A. urinae and A. sanguinicola, as A. sanguinicola shows lower response rates to nitrofurantoin (42%/50% success) 7
  • Elderly men with urinary tract abnormalities, chronic retention, or indwelling catheters are at highest risk 3, 4

Common Pitfalls to Avoid

Do not rely on trimethoprim-sulfamethoxazole or fluoroquinolones as empiric therapy, as their effectiveness against Aerococcus remains uncertain despite in vitro susceptibility. 4

  • Avoid treating asymptomatic bacteriuria, which fosters resistance and increases recurrence 1
  • Do not misidentify Aerococcus as alpha-hemolytic streptococci or enterococci, leading to inappropriate therapy 4
  • Failing to add an aminoglycoside in serious infections (bacteremia, endocarditis) results in inadequate bactericidal activity 6, 2
  • Inadequate treatment duration under 7 days leads to treatment failure 1

References

Guideline

Treatment of Urinary Tract Infection with Aerococcus urinae

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Aerococci and aerococcal infections.

The Journal of infection, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Three cases of serious infection caused by Aerococcus urinae.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.